Recent Updates — LMED

LataMed AI Corp. announced the effectiveness of its 5-for-1 forward stock split, which became effective at the opening of trading on July 15, 2026. The split involves a mandatory share exchange and a new CUSIP number, 21116R404. The company's common stock will temporarily trade under the symbol LMEDD for approximately twenty business days before reverting to LMED. LataMed AI Corp. is a digital health and artificial intelligence technology company focused on building telehealth infrastructure and AI-enabled healthcare solutions for emerging markets.

LataMed AI Corp. filed a Certificate of Change in Nevada to increase its authorized common stock from 700,000,000 to 3,500,000,000 shares and its authorized preferred stock from 300,000,000 to 1,500,000,000 shares. The filing also announced a five-for-one (5:1) forward stock split of all issued and outstanding shares of Common Stock. LataMed AI Corp. operates in the artificial intelligence sector, providing medical AI solutions.